[Diagnostic and prognostic value of serum miR-19a-3p in patients with multiple myeloma]

Zhonghua Xue Ye Xue Za Zhi. 2022 Jul 14;43(7):598-601. doi: 10.3760/cma.j.issn.0253-2727.2022.07.012.

[Article in Chinese]

Authors

X J Wei¹, L T Liu¹, H Sun¹, L G Qiu¹, M Hao¹

Affiliation

¹ State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

PMID: 36709139
PMCID: PMC9395561
DOI: 10.3760/cma.j.issn.0253-2727.2022.07.012

No abstract available

MeSH terms

Gene Expression Regulation, Neoplastic
Humans
MicroRNAs* / genetics
Multiple Myeloma* / diagnosis
Multiple Myeloma* / genetics
Prognosis

Substances

MicroRNAs

Grants and funding

基金项目：中央高校基本科研业务费（3332020055、2018PT31006）；国家自然科学基金（82170194）